financetom
Business
financetom
/
Business
/
Capital Group Investment Director Comments on Bank of Canada's Rate Cut
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Capital Group Investment Director Comments on Bank of Canada's Rate Cut
Dec 12, 2024 4:12 AM

06:53 AM EST, 12/12/2024 (MT Newswires) -- The Bank of Canada's Wednesday decision to cut rates is due to moderating inflation and slow economic growth, noted Naoum Tabet, Investment Director at Capital Group, following the reduction.

The BoC has implemented five rate cuts this year, with Wednesday's half-point reduction lowering the policy rate from 3.75% to 3.25%.

Before Canada's central bank decided to cut rates, the bond market had already anticipated it, with the short end of the yield curve moving down by 45bps, pointed out Tabet.

It's the second straight jumbo cut of 50bps and the BoC is expected to continue its easing cycle, with projections suggesting a total of four to five additional cuts over the next nine to 12 months, potentially bringing the rate down to around 2.25% by mid-2026, stated the investment director.

It's important to note that the recent depreciation of the Canadian dollar (CAD or loonie) may lead the BoC to avoid more outsized/jumbo cuts as it may lead to greater-than-expected deviations from United States monetary policy -- assuming Canadian economic conditions don't deteriorate more than anticipated, Tabet added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Takeda Pharmaceutical Says Colorectal Cancer Drug Received Marketing Approval in Japan
Takeda Pharmaceutical Says Colorectal Cancer Drug Received Marketing Approval in Japan
Sep 24, 2024
03:53 AM EDT, 09/24/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Tuesday it received approval from Japan's Ministry of Health to produce and market its Fruzaqla drug for advanced or recurrent colorectal cancer that cannot be cured or surgically treated and has progressed after chemotherapy. The approval is based on results from a phase 3 trial that met...
Oportun Financial Closes Warehouse Facility Extension
Oportun Financial Closes Warehouse Facility Extension
Sep 24, 2024
04:20 AM EDT, 09/24/2024 (MT Newswires) -- Oportun Financial ( OPRT ) said late Monday it closed an amendment and extension to its $306 million long-term warehouse facility. The facility includes Goldman Sachs as the senior lender and Jefferies as the mezzanine lender, as well as a new two-year revolving period, the company said. Price: 2.9400, Change: +0.02, Percent Change:...
Light & Wonder to Appeal Nevada District Court's Preliminary Injunction on Dragon Train
Light & Wonder to Appeal Nevada District Court's Preliminary Injunction on Dragon Train
Sep 24, 2024
04:36 AM EDT, 09/24/2024 (MT Newswires) -- Light & Wonder ( LNW ) said late Monday it received an order from the US District Court for the District of Nevada granting Aristocrat a preliminary injunction relating to the company's Dragon Train game. We respectfully disagree with the judge's decision and will promptly file an appeal, the company said. We will...
Minsud Resources' CEO Resigns; Replacement Announced
Minsud Resources' CEO Resigns; Replacement Announced
Sep 24, 2024
05:15 PM EDT, 09/18/2024 (MT Newswires) -- Minsud Resources ( MDSQF ) said late Wednesday said Ramiro Massa resigned as its chief executive officer, effective immediately. To keep his expertise, Massa has been appointed to the board of directors, the company added. Agustin Dranovsky, currently a director, will take over as CEO, the company said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved